{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T22:40:56Z","timestamp":1793745656998,"version":"4.6.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"General Program of Hebei Natural Science Foundation","award":["H2024206433"],"award-info":[{"award-number":["H2024206433"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-38411-z","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T16:03:43Z","timestamp":1772553823000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Ginsenoside Rb1 alleviates endothelial dysfunction and vascular remodeling in preeclampsia via activation of the PI3K-Akt-eNOS pathway"],"prefix":"10.1038","volume":"16","author":[{"given":"Wen","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baolian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengshu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianghua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,3]]},"reference":[{"issue":"1","key":"38411_CR1","first-page":"e51512","volume":"16","author":"DD Sharma","year":"2024","unstructured":"Sharma, D. D. et al. The management of preeclampsia: a comprehensive review of current practices and future directions. Cureus 16 (1), e51512 (2024).","journal-title":"Cureus"},{"key":"38411_CR2","doi-asserted-by":"crossref","unstructured":"Tomimatsu, T. et al. Preeclampsia: maternal systemic vascular disorder caused by generalized endothelial dysfunction due to placental antiangiogenic factors. Int. J. Mol. Sci. 20, 17 (2019).","DOI":"10.3390\/ijms20174246"},{"key":"38411_CR3","doi-asserted-by":"publisher","first-page":"102480","DOI":"10.1016\/j.bpobgyn.2024.102480","volume":"94","author":"JM Roberts","year":"2024","unstructured":"Roberts, J. M. Preeclampsia epidemiology(ies) and pathophysiology(ies). Best Pract. Res. Clin. Obstet. Gynaecol. 94, 102480 (2024).","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"issue":"4","key":"38411_CR4","doi-asserted-by":"publisher","first-page":"e626","DOI":"10.1016\/S2214-109X(24)00560-6","volume":"13","author":"JA Cresswell","year":"2025","unstructured":"Cresswell, J. A. et al. Global and regional causes of maternal deaths 2009-20: a WHO systematic analysis. Lancet Glob Health. 13 (4), e626\u2013e634 (2025).","journal-title":"Lancet Glob Health"},{"issue":"14","key":"38411_CR5","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1016\/j.jacc.2020.08.014","volume":"76","author":"CW Ives","year":"2020","unstructured":"Ives, C. W. et al. Preeclampsia-Pathophysiology and clinical presentations: JACC State-of-the-Art review. J. Am. Coll. Cardiol. 76 (14), 1690\u20131702 (2020).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"11","key":"38411_CR6","doi-asserted-by":"publisher","first-page":"103787","DOI":"10.1016\/j.drudis.2023.103787","volume":"28","author":"A Jain","year":"2023","unstructured":"Jain, A. & Jain, I. ET-traps: potential therapeutics for preeclampsia. Drug Discov Today. 28 (11), 103787 (2023).","journal-title":"Drug Discov Today"},{"issue":"4","key":"38411_CR7","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1159\/000482004","volume":"42","author":"YP Lu","year":"2017","unstructured":"Lu, Y. P. et al. Plasma ET-1 concentrations are elevated in pregnant women with hypertension -Meta-Analysis of clinical studies. Kidney Blood Press. Res. 42 (4), 654\u2013663 (2017).","journal-title":"Kidney Blood Press. Res."},{"issue":"4","key":"38411_CR8","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1161\/HYPERTENSIONAHA.123.21716","volume":"81","author":"EL Schiffrin","year":"2024","unstructured":"Schiffrin, E. L. & Pollock, D. M. Endothelin system in hypertension and chronic kidney disease. Hypertension 81 (4), 691\u2013701 (2024).","journal-title":"Hypertension"},{"key":"38411_CR9","doi-asserted-by":"crossref","unstructured":"Chiang, Y. T., Seow, K. M. & Chen, K. H. The pathophysiological, genetic, and hormonal changes in preeclampsia: a systematic review of the molecular mechanisms. Int. J. Mol. Sci. 25, 8  (2024).","DOI":"10.3390\/ijms25084532"},{"key":"38411_CR10","doi-asserted-by":"crossref","unstructured":"Jena, M. K. et al. Pathogenesis of preeclampsia and therapeutic approaches targeting the placenta. Biomolecules  10, 6 (2020).","DOI":"10.3390\/biom10060953"},{"issue":"3\u20134","key":"38411_CR11","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.vph.2011.12.006","volume":"56","author":"C Pan","year":"2012","unstructured":"Pan, C. et al. Panax Notoginseng and its components decreased hypertension via stimulation of endothelial-dependent vessel dilatation. Vascul Pharmacol. 56 (3\u20134), 150\u2013158 (2012).","journal-title":"Vascul Pharmacol."},{"issue":"3","key":"38411_CR12","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1097\/FJC.0b013e3180cab12e","volume":"50","author":"F He","year":"2007","unstructured":"He, F. et al. Protective effects of ginsenoside Rb1 on human umbilical vein endothelial cells in vitro. J. Cardiovasc. Pharmacol. 50 (3), 314\u2013320 (2007).","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"38411_CR13","doi-asserted-by":"crossref","unstructured":"Yuqiong, W. et al. The osteogenesis of ginsenoside Rb1 incorporated silk\/micro-nano hydroxyapatite\/sodium alginate composite scaffolds for calvarial defect. Int. J. Oral Sci.  14, 10 (2022).","DOI":"10.1038\/s41368-022-00157-5"},{"key":"38411_CR14","doi-asserted-by":"crossref","unstructured":"Huixia, L. et al. Ginsenoside-Rb1-Mediated Anti-angiogenesis via regulating PEDF and miR-33a through the activation of PPAR-\u03b3 pathway. Front. Pharmacol. 8, 856  (2017).","DOI":"10.3389\/fphar.2017.00783"},{"key":"38411_CR15","doi-asserted-by":"crossref","unstructured":"Zhang, S. et al. The role of Ca(2+)\/PI3K\/Akt\/eNOS\/NO pathway in astragaloside IV-induced inhibition of endothelial inflammation triggered by angiotensin II. Mediators Inflamm. 2024,  3193950  (2024).","DOI":"10.1155\/2024\/3193950"},{"key":"38411_CR16","doi-asserted-by":"crossref","unstructured":"Ping, Z. et al. Attenuation of TNF-\u03b1-Induced inflammatory injury in endothelial cells by ginsenoside Rb1 via inhibiting NF-\u03baB, JNK and p38 signaling pathways. Front. Pharmacol. 8, 2560 (2017).","DOI":"10.3389\/fphar.2017.00464"},{"key":"38411_CR17","doi-asserted-by":"crossref","unstructured":"Hui, C. et al. Ginsenoside Rb1 inhibits tumor necrosis factor-alpha-induced vascular cell adhesion molecule-1 expression in human endothelial cells. Biol. Pharm. Bull. 31, 11 (2008).","DOI":"10.1248\/bpb.31.2050"},{"key":"38411_CR18","doi-asserted-by":"crossref","unstructured":"Lele, C. et al. Effect of anti-skin disorders of ginsenosides- a systematic review. J. Ginseng Res.  47, 5  (2023).","DOI":"10.1016\/j.jgr.2023.04.005"},{"key":"38411_CR19","doi-asserted-by":"crossref","unstructured":"Lijiahui, L. et al. Dapagliflozin improves the dysfunction of human umbilical vein endothelial cells (HUVECs) by downregulating high glucose\/high fat-induced autophagy through inhibiting SGLT-2. J. Diabetes Compl. 39, 1  (2024).","DOI":"10.1016\/j.jdiacomp.2024.108907"},{"key":"38411_CR20","doi-asserted-by":"crossref","unstructured":"Haochong, S. et al. Lycium barbarum polysaccharide\u2019s protective effects against PM(2.5)-induced cellular senescence in HUVECs. Ecotoxicol. Environ. Saf., 274, 36  (2024).","DOI":"10.1016\/j.ecoenv.2024.116232"},{"key":"38411_CR21","doi-asserted-by":"crossref","unstructured":"Fengxia, L. et al. Hydrogen sulfide protects against high Glucose-Induced human umbilical vein endothelial cell injury through activating PI3K\/Akt\/eNOS pathway. Drug Des. Devel Ther. 14, 745  (2020).","DOI":"10.2147\/DDDT.S242521"},{"issue":"8","key":"38411_CR22","doi-asserted-by":"publisher","first-page":"112744","DOI":"10.1016\/j.isci.2025.112744","volume":"28","author":"K Li","year":"2025","unstructured":"Li, K. et al. CGKRK-targeted lipid nanoparticles enhance in vivo Rosiglitazone delivery to the placenta to ameliorate murine preeclampsia. iScience 28 (8), 112744 (2025).","journal-title":"iScience"},{"key":"38411_CR23","doi-asserted-by":"crossref","unstructured":"Kamrani, A. et al. Regulation of PI3K\/Akt in preeclampsia: an examination of its pathological role and therapeutic potential (Naunyn Schmiedebergs. Arch. Pharmacol. (2025).","DOI":"10.1007\/s00210-025-04472-6"},{"issue":"1","key":"38411_CR24","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41572-023-00417-6","volume":"9","author":"E Dimitriadis","year":"2023","unstructured":"Dimitriadis, E. et al. Pre-eclampsia. Nat. Reviews Disease Primers. 9 (1), 8 (2023).","journal-title":"Nat. Reviews Disease Primers"},{"issue":"3","key":"38411_CR25","doi-asserted-by":"publisher","first-page":"180","DOI":"10.4274\/tjod.galenos.2024.99132","volume":"21","author":"F Fitriana","year":"2024","unstructured":"Fitriana, F. et al. Evaluation of placental bed uterine in L-NAME-induced early-onset preeclampsia (EO-PE) like the rat model. Turk. J. Obstet. Gynecol. 21 (3), 180\u2013189 (2024).","journal-title":"Turk. J. Obstet. Gynecol."},{"issue":"4","key":"38411_CR26","first-page":"489","volume":"16","author":"Y Song","year":"2024","unstructured":"Song, Y., Chen, C. & Li, W. Ginsenoside Rb(1) in cardiovascular and cerebrovascular diseases: a review of therapeutic potentials and molecular mechanisms. Chin. Herb. Med. 16 (4), 489\u2013504 (2024).","journal-title":"Chin. Herb. Med."},{"issue":"1\u20132","key":"38411_CR27","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0009-8981(01)00751-3","volume":"317","author":"P Vural","year":"2002","unstructured":"Vural, P. Nitric oxide\/endothelin-1 in preeclampsia. Clin. Chim. Acta. 317 (1\u20132), 65\u201370 (2002).","journal-title":"Clin. Chim. Acta"},{"issue":"2s","key":"38411_CR28","doi-asserted-by":"publisher","first-page":"S973","DOI":"10.1016\/j.ajog.2020.10.025","volume":"226","author":"BA Bakrania","year":"2022","unstructured":"Bakrania, B. A., George, E. M. & Granger, J. P. Animal models of preeclampsia: investigating pathophysiology and therapeutic targets. Am. J. Obstet. Gynecol. 226 (2s), S973\u2013s987 (2022).","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"2","key":"38411_CR29","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jgr.2017.01.008","volume":"42","author":"P Mohanan","year":"2018","unstructured":"Mohanan, P. et al. Molecular signaling of ginsenosides Rb1, Rg1, and Rg3 and their mode of actions. J. Ginseng Res. 42 (2), 123\u2013132 (2018).","journal-title":"J. Ginseng Res."},{"issue":"1","key":"38411_CR30","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12916-023-02807-9","volume":"21","author":"J Wang","year":"2023","unstructured":"Wang, J. et al. Alpha-2-macroglobulin is involved in the occurrence of early-onset pre-eclampsia via its negative impact on uterine spiral artery remodeling and placental angiogenesis. BMC Med. 21 (1), 90 (2023).","journal-title":"BMC Med."},{"issue":"4","key":"38411_CR31","first-page":"3175","volume":"20","author":"J Ye","year":"2019","unstructured":"Ye, J. et al. Ginsenoside Rb1 prevents steroid\u2013induced avascular necrosis of the femoral head through the bone morphogenetic protein\u20132 and vascular endothelial growth factor pathway. Mol. Med. Rep. 20 (4), 3175\u20133181 (2019).","journal-title":"Mol. Med. Rep."},{"issue":"13","key":"38411_CR32","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.phymed.2010.06.012","volume":"17","author":"XQ Yi","year":"2010","unstructured":"Yi, X. Q. et al. Total ginsenosides increase coronary perfusion flow in isolated rat hearts through activation of PI3K\/Akt-eNOS signaling. Phytomedicine 17 (13), 1006\u20131015 (2010).","journal-title":"Phytomedicine"},{"key":"38411_CR33","doi-asserted-by":"crossref","unstructured":"Chang-Yan, L. et al. Ginsenoside Rb1 attenuates cardiomyocyte apoptosis induced by myocardial ischemia reperfusion injury through mTOR signal pathway. Biomed. Pharmacother 125, 560 (2020).","DOI":"10.1016\/j.biopha.2020.109913"},{"key":"38411_CR34","unstructured":"Yichuan, J. et al. Ginsenoside Rg3 induces ginsenoside Rb1-comparable cardioprotective effects independent of reducing blood pressure in spontaneously hypertensive rats. Exp. Ther. Med. 14, 5 (2017)."},{"key":"38411_CR35","doi-asserted-by":"crossref","unstructured":"Huimin, C. et al. Ginsenoside Rb1 exerts neuroprotective effects through regulation of Lactobacillus helveticus abundance and GABA(A) receptor expression. J. Ginseng Res. 44, 1  (2020).","DOI":"10.1016\/j.jgr.2018.09.002"},{"key":"38411_CR36","doi-asserted-by":"crossref","unstructured":"Ning, J. et al. Ginsenoside Rb1 produces Antidepressant-Like effects in a chronic social defeat stress model of depression through the BDNF-Trkb signaling pathway. Front. Pharmacol. 12, 526 (2021).","DOI":"10.3389\/fphar.2021.680903"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-38411-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-38411-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-38411-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T02:02:48Z","timestamp":1775786568000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-38411-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,3]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["38411"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-38411-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,3]]},"assertion":[{"value":"6 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Patients: The study was approved by the Ethics Committee of the Second Hospital of Hebei Medical University (Approval No.: 2025-R012 [Clinical]), and written informed consent was obtained from all participants. Animals: All procedures were approved by the Animal Ethics Committee of the Second Hospital of Hebei Medical University (Approval No.: 2025-AE-037) and adhered to institutional and national guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"11893"}}